語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Antimicrobial resistancebeyond the b...
~
Weber, J. Todd.
Antimicrobial resistancebeyond the breakpoint /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Antimicrobial resistancevolume editor, J. Todd Weber.
其他題名:
beyond the breakpoint /
其他作者:
Weber, J. Todd.
出版者:
Basel :S. Karger,2010
面頁冊數:
1 online resource :ill. (some col.)
附註:
When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
標題:
Drug resistance in microorganisms.
電子資源:
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=253645
ISBN:
9783805593243
Antimicrobial resistancebeyond the breakpoint /
Antimicrobial resistance
beyond the breakpoint /[electronic resource] :volume editor, J. Todd Weber. - Basel :S. Karger,2010 - 1 online resource :ill. (some col.) - Issues in infectious diseases,v. 61662-3819 ;. - Issues in infectious diseases ;v. 6..
When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
Includes bibliographical references and indexes.
Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.Each chapter provides essential background and examines the evidence for an important aspect of prevention and control, treatment strategy or policy decision. Prevention and control strategies are analyzed for inappropriate antimicrobial use, fluoroquinolone-resistant organisms, health-care associated infections and parasitic diseases. Furthermore, treatment strategies for changing resistance patterns are explored for community-acquired pneumonia during an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase producing organisms and fungi. Data for policy making are presented in articles that detail the costs of antimicrobial-resistant infections in healthcare settings and the threat of resistance with the introduction of antiretroviral therapy for large populations in the developing world. These reviews show where interventions, surveillance and research will be most useful in the future. Antimicrobial Resistance is an invaluable contribution for infectious disease physicians and public health officials who are interested in the prevention of antimicrobial-resistant infections.
ISBN: 9783805593243Subjects--Topical Terms:
192960
Drug resistance in microorganisms.
LC Class. No.: QR177 / .A5855 2010
Dewey Class. No.: 616.9/041
National Library of Medicine Call No.: 2010 D-858
Antimicrobial resistancebeyond the breakpoint /
LDR
:02462cmm a2200265 a 4500
001
310142
003
SZ-BaSKA
005
20110603112119.0
006
m d
007
cr cn|||||||||
008
111213s2010 sz a ob 001 0 eng d
020
$a
9783805593243
035
$a
253645
040
$a
szbaska
050
0 0
$a
QR177
$b
.A5855 2010
060
0 0
$a
2010 D-858
060
1 0
$a
QW 45
$b
A6306 2010
082
0 0
$a
616.9/041
$2
22
245
0 0
$a
Antimicrobial resistance
$h
[electronic resource] :
$b
beyond the breakpoint /
$c
volume editor, J. Todd Weber.
260
$a
Basel :
$b
S. Karger,
$c
2010
300
$a
1 online resource :
$b
ill. (some col.)
490
1
$a
Issues in infectious diseases,
$x
1662-3819 ;
$v
v. 6
500
$a
When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
504
$a
Includes bibliographical references and indexes.
520
$a
Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.Each chapter provides essential background and examines the evidence for an important aspect of prevention and control, treatment strategy or policy decision. Prevention and control strategies are analyzed for inappropriate antimicrobial use, fluoroquinolone-resistant organisms, health-care associated infections and parasitic diseases. Furthermore, treatment strategies for changing resistance patterns are explored for community-acquired pneumonia during an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase producing organisms and fungi. Data for policy making are presented in articles that detail the costs of antimicrobial-resistant infections in healthcare settings and the threat of resistance with the introduction of antiretroviral therapy for large populations in the developing world. These reviews show where interventions, surveillance and research will be most useful in the future. Antimicrobial Resistance is an invaluable contribution for infectious disease physicians and public health officials who are interested in the prevention of antimicrobial-resistant infections.
650
0
$a
Drug resistance in microorganisms.
$3
192960
650
1 2
$a
Drug Resistance, Microbial.
$3
229505
700
1
$a
Weber, J. Todd.
$3
521001
830
0
$a
Issues in infectious diseases ;
$v
v. 6.
$3
521002
856
4 0
$u
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=253645
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000055842
電子館藏
1圖書
電子書
EB QR177 .A5855 2010
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=253645
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入